Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

October 12, 2022

Study Completion Date

March 8, 2024

Conditions
Fibrosis LungSystemic Sclerosis
Interventions
DIAGNOSTIC_TEST

Bronchoscopy with lavage

During an elective bronchoscopy procedure, the bronchoscope will be wedged into an affected lung segment guided by CT scanning. When involved an anterior segment will be used to maximize return. After wedging the bronchoscope, 120ml of sterile 0.09% normal saline will be instilled. Up to 40-60 mL of BAL fluid will be obtained for analysis during each sampling.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT03438032 - Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD | Biotech Hunter | Biotech Hunter